Search

Your search keyword '"Pursuing Later Treatment Option II project team"' showing total 2 results
Start Over Author "Pursuing Later Treatment Option II project team"
2 results on '"Pursuing Later Treatment Option II project team"'

1. Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study

Author

Castagliola, D, Ledergerber, B, Torti, Carlo, van Sighem, A, Podzamczer, D, Mocroft, A, Dorrucci, M, Masquelier, B, de Luca, A, Jansen, K, De Wit, S, Obel, N, Fätkenheuer, G, Touloumi, G, Mussini, C, Castagna, A, Stephan, C, Garcia, F, Zangerle, R, Duval, X, Pérez Hoyos, S, Meyer, L, Ghosn, J, Fabre Colin, C, Kjaer, J, Chene, G, Grarup, J, Costagliola, D, Lodwick, R, Phillips, A, Pursuing Later Treatment Option II project team, Observational HIV Epidemiological Research Europe Group, Costagliola, D, Lodwick, R, Ledergerber, B, Collaboration Of Observational Hiv Epidemiological Research Europe (COHERE) Grp, Castagna, Antonella, Other departments, AII - Amsterdam institute for Infection and Immunity, APH - Amsterdam Public Health, Global Health, and Infectious diseases

Subjects
Adult, Male, medicine.medical_specialty, Adolescent, Anti-HIV Agents, HIV-1, CD4 Lymphocyte Count, Cohort Studies, Female, HIV Infections, Humans, Middle Aged, RNA, Viral, Regression Analysis, Retrospective Studies, Young Adult, Settore MED/17 - MALATTIE INFETTIVE, 03 medical and health sciences, symbols.namesake, 0302 clinical medicine, Acquired immunodeficiency syndrome (AIDS), RNA, Viral -- blood, Internal medicine, medicine, HIV, AIDS, viral load, Protease inhibitor (pharmacology), 030212 general & internal medicine, Poisson regression, Young adult, Pathologie maladies infectieuses, HIV Infections -- blood -- drug therapy -- virology, 0303 health sciences, 030306 microbiology, business.industry, Incidence (epidemiology), Retrospective cohort study, Sciences bio-médicales et agricoles, medicine.disease, 3. Good health, Infectious Diseases, Immunology, symbols, RNA, Viral, Anti-HIV Agents -- therapeutic use, business, Viral load, Cohort study
Abstract

Limited treatment options have been available for people with HIV who have had virological failure of the three original classes of HIV antiretroviral drugs-so-called triple-class virological failure (TCVF). However, introduction of new drugs and drug classes might have improved outcomes. We aimed to assess trends in virological and clinical outcomes for individuals with TCVF in 2000-09., info:eu-repo/semantics/published

Published
2012

2. Predictors of CD4 cell counts of HIV-1 - infected persons after virologic failure to all three original antiretroviral drug classes

Author

Ledergerber, B, Costagliola, D, Lodwick, R, Torti, Carlo, Sighem, Av, Podzamczer, D, Mocroft, A, Dorrucci, M, Masquelier, B, Günthard, Hf, de Luca, A, Michalik, C, De Wit, S, Obel, N, Fätkenheuer, G, Chrysos, G, Mussini, C, Castagna, A, Stephan, C, García, F, Zangerle, R, Duval, X, Perez Hoyos, S, Meyer, L, Ghosn, J, Fabre Colin, C, Kjaer, J, Grarup, J, Chêne, G, and The Pursuing Later Treatment Option II project team for the Collaboration of Observational HIV Epidemiological Research Europe Group, Phillips A.

Catalog

Books, media, physical & digital resources
See catalog results